Insulin modulation of an endothelial nitric oxide component present in the α2- and β-adrenergic responses in human forearm

Giuseppe Lembo, Guido Iaccarino, Carmine Vecchione, Emanuele Barbato, Raffaele Izzo, Dario Fontana, Bruno Trimarco

Research output: Contribution to journalArticle

Abstract

We explored in 51 normal subjects, distributed in various series of experiments, whether endothelium nitric oxide may play a role in insulin modulation of α2- and β-adrenergic-evoked vascular responses. In particular, we examined the forearm blood flew response (FBF, ml·min- 1·dl-1) to intra-brachial infusion of BHT-933 (0.5, 1, and 2 μg·min- 1·dl-1) or isoproterenol (1, 3, and 6 ng·min-1·dl-1) in control conditions, during intrabrachial infusion of insulin alone (0.05 mU·kg- 1·min-1) and associated with L-N-monomethylarginine (L-NMMA) (0.05 μg·min-1·dl-1), a nitric oxide synthase inhibitor. In control conditions both BHT-933 and isoproterenol induced a dose-dependent vascular response. Local hyperinsulinemia (deep venous plasma insulin 68.5±4 μU/ml) did not change basal FBF whereas attenuated BHT-933 vasoconstriction and enhanced isoproterenol vasodilation. L-NMMA reduced basal FBF and abolished the insulin effect on BHT-933 and isoproterenol response. To clarify whether:a nitric oxide component is included in α2- and β-adrenergic response and may be responsible for insulin vascular effect, we further examined BHT-933 and isoproterenol responses during nitric oxide inhibition. Interestingly, L-NMMA potentiated the BHT-933 vasoconstriction and attenuated the isoproterenol vasodilation and, in these conditions, insulin was no more able to exhibit its vascular effects. Finally, to rule out the possibility that the conteracting effect of L-NMMA may not be specifically related to insulin action, dose-response curves to phenylephrine (0.5, 1, and 2 μg·min-1·dl-1) or sodium nitroprusside (1, 2, and 4 μg·min-1·dl- 1) were also performed. Both insulin and L-NMMA were unable to alter the phenylephrine-induced vasoconstriction and the sodium nitroprusside vasodilation. In conclusion, our data demonstrate an endothelial nitric oxide component in the α2- and β-adrenergic vascular responses which is the target of the insulin vascular action.

Original languageEnglish
Pages (from-to)2007-2014
Number of pages8
JournalJournal of Clinical Investigation
Volume100
Issue number8
Publication statusPublished - Oct 15 1997

Fingerprint

Forearm
Adrenergic Agents
Nitric Oxide
Insulin
Isoproterenol
Blood Vessels
Vasoconstriction
Vasodilation
Nitroprusside
Phenylephrine
Hyperinsulinism
Nitric Oxide Synthase
Endothelium
azepexole
Arm

Keywords

  • Adrenergic receptors
  • Endothelium
  • Forearm blood flow
  • Insulin
  • Sympathetic nervous system

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Insulin modulation of an endothelial nitric oxide component present in the α2- and β-adrenergic responses in human forearm. / Lembo, Giuseppe; Iaccarino, Guido; Vecchione, Carmine; Barbato, Emanuele; Izzo, Raffaele; Fontana, Dario; Trimarco, Bruno.

In: Journal of Clinical Investigation, Vol. 100, No. 8, 15.10.1997, p. 2007-2014.

Research output: Contribution to journalArticle

Lembo, Giuseppe ; Iaccarino, Guido ; Vecchione, Carmine ; Barbato, Emanuele ; Izzo, Raffaele ; Fontana, Dario ; Trimarco, Bruno. / Insulin modulation of an endothelial nitric oxide component present in the α2- and β-adrenergic responses in human forearm. In: Journal of Clinical Investigation. 1997 ; Vol. 100, No. 8. pp. 2007-2014.
@article{4aa8fe0d75d14de4b3299e477ced6fc5,
title = "Insulin modulation of an endothelial nitric oxide component present in the α2- and β-adrenergic responses in human forearm",
abstract = "We explored in 51 normal subjects, distributed in various series of experiments, whether endothelium nitric oxide may play a role in insulin modulation of α2- and β-adrenergic-evoked vascular responses. In particular, we examined the forearm blood flew response (FBF, ml·min- 1·dl-1) to intra-brachial infusion of BHT-933 (0.5, 1, and 2 μg·min- 1·dl-1) or isoproterenol (1, 3, and 6 ng·min-1·dl-1) in control conditions, during intrabrachial infusion of insulin alone (0.05 mU·kg- 1·min-1) and associated with L-N-monomethylarginine (L-NMMA) (0.05 μg·min-1·dl-1), a nitric oxide synthase inhibitor. In control conditions both BHT-933 and isoproterenol induced a dose-dependent vascular response. Local hyperinsulinemia (deep venous plasma insulin 68.5±4 μU/ml) did not change basal FBF whereas attenuated BHT-933 vasoconstriction and enhanced isoproterenol vasodilation. L-NMMA reduced basal FBF and abolished the insulin effect on BHT-933 and isoproterenol response. To clarify whether:a nitric oxide component is included in α2- and β-adrenergic response and may be responsible for insulin vascular effect, we further examined BHT-933 and isoproterenol responses during nitric oxide inhibition. Interestingly, L-NMMA potentiated the BHT-933 vasoconstriction and attenuated the isoproterenol vasodilation and, in these conditions, insulin was no more able to exhibit its vascular effects. Finally, to rule out the possibility that the conteracting effect of L-NMMA may not be specifically related to insulin action, dose-response curves to phenylephrine (0.5, 1, and 2 μg·min-1·dl-1) or sodium nitroprusside (1, 2, and 4 μg·min-1·dl- 1) were also performed. Both insulin and L-NMMA were unable to alter the phenylephrine-induced vasoconstriction and the sodium nitroprusside vasodilation. In conclusion, our data demonstrate an endothelial nitric oxide component in the α2- and β-adrenergic vascular responses which is the target of the insulin vascular action.",
keywords = "Adrenergic receptors, Endothelium, Forearm blood flow, Insulin, Sympathetic nervous system",
author = "Giuseppe Lembo and Guido Iaccarino and Carmine Vecchione and Emanuele Barbato and Raffaele Izzo and Dario Fontana and Bruno Trimarco",
year = "1997",
month = "10",
day = "15",
language = "English",
volume = "100",
pages = "2007--2014",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "8",

}

TY - JOUR

T1 - Insulin modulation of an endothelial nitric oxide component present in the α2- and β-adrenergic responses in human forearm

AU - Lembo, Giuseppe

AU - Iaccarino, Guido

AU - Vecchione, Carmine

AU - Barbato, Emanuele

AU - Izzo, Raffaele

AU - Fontana, Dario

AU - Trimarco, Bruno

PY - 1997/10/15

Y1 - 1997/10/15

N2 - We explored in 51 normal subjects, distributed in various series of experiments, whether endothelium nitric oxide may play a role in insulin modulation of α2- and β-adrenergic-evoked vascular responses. In particular, we examined the forearm blood flew response (FBF, ml·min- 1·dl-1) to intra-brachial infusion of BHT-933 (0.5, 1, and 2 μg·min- 1·dl-1) or isoproterenol (1, 3, and 6 ng·min-1·dl-1) in control conditions, during intrabrachial infusion of insulin alone (0.05 mU·kg- 1·min-1) and associated with L-N-monomethylarginine (L-NMMA) (0.05 μg·min-1·dl-1), a nitric oxide synthase inhibitor. In control conditions both BHT-933 and isoproterenol induced a dose-dependent vascular response. Local hyperinsulinemia (deep venous plasma insulin 68.5±4 μU/ml) did not change basal FBF whereas attenuated BHT-933 vasoconstriction and enhanced isoproterenol vasodilation. L-NMMA reduced basal FBF and abolished the insulin effect on BHT-933 and isoproterenol response. To clarify whether:a nitric oxide component is included in α2- and β-adrenergic response and may be responsible for insulin vascular effect, we further examined BHT-933 and isoproterenol responses during nitric oxide inhibition. Interestingly, L-NMMA potentiated the BHT-933 vasoconstriction and attenuated the isoproterenol vasodilation and, in these conditions, insulin was no more able to exhibit its vascular effects. Finally, to rule out the possibility that the conteracting effect of L-NMMA may not be specifically related to insulin action, dose-response curves to phenylephrine (0.5, 1, and 2 μg·min-1·dl-1) or sodium nitroprusside (1, 2, and 4 μg·min-1·dl- 1) were also performed. Both insulin and L-NMMA were unable to alter the phenylephrine-induced vasoconstriction and the sodium nitroprusside vasodilation. In conclusion, our data demonstrate an endothelial nitric oxide component in the α2- and β-adrenergic vascular responses which is the target of the insulin vascular action.

AB - We explored in 51 normal subjects, distributed in various series of experiments, whether endothelium nitric oxide may play a role in insulin modulation of α2- and β-adrenergic-evoked vascular responses. In particular, we examined the forearm blood flew response (FBF, ml·min- 1·dl-1) to intra-brachial infusion of BHT-933 (0.5, 1, and 2 μg·min- 1·dl-1) or isoproterenol (1, 3, and 6 ng·min-1·dl-1) in control conditions, during intrabrachial infusion of insulin alone (0.05 mU·kg- 1·min-1) and associated with L-N-monomethylarginine (L-NMMA) (0.05 μg·min-1·dl-1), a nitric oxide synthase inhibitor. In control conditions both BHT-933 and isoproterenol induced a dose-dependent vascular response. Local hyperinsulinemia (deep venous plasma insulin 68.5±4 μU/ml) did not change basal FBF whereas attenuated BHT-933 vasoconstriction and enhanced isoproterenol vasodilation. L-NMMA reduced basal FBF and abolished the insulin effect on BHT-933 and isoproterenol response. To clarify whether:a nitric oxide component is included in α2- and β-adrenergic response and may be responsible for insulin vascular effect, we further examined BHT-933 and isoproterenol responses during nitric oxide inhibition. Interestingly, L-NMMA potentiated the BHT-933 vasoconstriction and attenuated the isoproterenol vasodilation and, in these conditions, insulin was no more able to exhibit its vascular effects. Finally, to rule out the possibility that the conteracting effect of L-NMMA may not be specifically related to insulin action, dose-response curves to phenylephrine (0.5, 1, and 2 μg·min-1·dl-1) or sodium nitroprusside (1, 2, and 4 μg·min-1·dl- 1) were also performed. Both insulin and L-NMMA were unable to alter the phenylephrine-induced vasoconstriction and the sodium nitroprusside vasodilation. In conclusion, our data demonstrate an endothelial nitric oxide component in the α2- and β-adrenergic vascular responses which is the target of the insulin vascular action.

KW - Adrenergic receptors

KW - Endothelium

KW - Forearm blood flow

KW - Insulin

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=0030838186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030838186&partnerID=8YFLogxK

M3 - Article

C2 - 9329964

AN - SCOPUS:0030838186

VL - 100

SP - 2007

EP - 2014

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 8

ER -